Yahoo Finance • 24 days ago
FOSTER CITY, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted equity awards covering an aggregate of 966,000 shares of its commo... Full story
Yahoo Finance • 2 months ago
ALISO VIEJO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately held ophthalmic biotechnology company, today announced the appointment of Elizabeth (Liz) O’Farrell to its Board of Directors as an Independent Director... Full story
Yahoo Finance • 2 months ago
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Geron Corporation (“Geron” or “the Company”) (NASDAQ: GERN) investors... Full story
Yahoo Finance • 2 months ago
Geron Corporation (NASDAQ:GERN), a biotechnology company focused on developing innovative therapies for hematologic malignancies, has been navigating a complex landscape of opportunities and challenges. The company’s flagship product, Ryte... Full story
Yahoo Finance • 2 months ago
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf of long-term stockholders... Full story
Yahoo Finance • 2 months ago
Earnings Call Insights: Geron Corporation (GERN) Q2 2025 MANAGEMENT VIEW * Dawn Carter Bir, Interim President and CEO, highlighted the appointment of Harout Semerjian as Geron's new President and CEO, noting his commercial expertise in... Full story
Yahoo Finance • 2 months ago
Key Points GAAP revenue reached $49.0 million in Q2 2025, beating analyst estimates for both GAAP EPS and revenue. GAAP earnings per share improved to $(0.02). RYTELO demand rose 17% quarter-over-quarter following a challenging start to t... Full story
Yahoo Finance • 2 months ago
* Geron (NASDAQ:GERN [https://seekingalpha.com/symbol/GERN]) is scheduled to announce Q2 earnings results on Wednesday, August 6th, before market open. * The consensus EPS Estimate is -$0.03 [https://seekingalpha.com/symbol/GERN/earnin... Full story
Yahoo Finance • 3 months ago
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, is investigating potential violations of federal and state securities laws by certain officers and directors of Geron Corporation (NASDAQ: GERN), Viatris Inc. (NASDAQ: VT... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf of long-term stockholders f... Full story
Yahoo Finance • 5 months ago
We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Geron Corporation (NASDAQ:GERN) stands against other best low priced biotech stocks to buy now. Is Now the... Full story
Yahoo Finance • 5 months ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Geron To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Gero... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Geron Corporation (NASDAQ:... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Geron Corporation (NASDAQ: GERN). Shareholders who purchased shares of GERN during the class period listed are encouraged to co... Full story
Yahoo Finance • 5 months ago
ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors of the May 12, 2025 deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Geron Corporation (GERN) The shareholder class... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Geron Corporation (NASDAQ: GERN) between February 28, 2024 and February 25, 2025, both dates inclusiv... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover loss... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) and certain officers. The class action, filed in the Unite... Full story
Yahoo Finance • 5 months ago
SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and February 25, 2025, inclusive... Full story
Yahoo Finance • 5 months ago
NEW YORK, May 02, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Geron Corporation ("Geron" or the "Company") (NASDAQ: GERN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover loss... Full story